Joint Formulary & PAD

A-test drug - Test B

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Auto-injector
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Narrative entered here will appear on the Formulary page. Keep wording to a minimum and include key points. For example

Restricted to endocrinology only.

Tablets can be crushed for patients with swallowing difficulties (off-label use)

Use this space to write useful information. This narrative does not appear on the formulary page but may be useful in conveying more lengthy advice. For example

People taking clozapine require mandatory blood tests up to every 4 weeks which will normally be organised by the MH team as they retain clinical responsibility for prescribing. The supplying pharmacy will only issue clozapine with an up-to-date blood test result

Or

Pregnancy Prevention Programme applies - The Medicines Safety Committee recommend the MHRA 'Guidance on contraceptive methods and frequency of pregnancy testing to reduce inadvertent exposures during pregnancy in a woman taking a medicine of teratogenic potential' which can be found here (add link)

 

Status 2

Red
Formulations :
  • Capsules
Associated Icons :
Restrictions / Comments :
Important

SASH: Not for use in Sussex patients

PAD Profile

ChemicalSubstance :
A-test drug
Indication :
Test B
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Traffic Light Entries :
2

Other Indications

Below are listed other indications that A-test drug is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Test B.

  • No records returned.

Committee Recommendations (0)

  • No records returned.